Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q2 FY2014
As of Jun 30, 2014
Q1 FY2014
As of Mar 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Q1 FY2013
As of Mar 31, 2013
Q4 FY2012
As of Dec 31, 2012
Q3 FY2012
As of Sep 30, 2012
Current assets:
Cash and cash equivalents
Restricted cash
Marketable securities
Accounts receivable, net of allowances of $76,072 and $75,798 at June 30, 2017 and December 31, 2016, respectively
Inventories, net
Deferred tax assets
Prepaid expenses and other current assets
Assets held for sale - current
Total current assets
Property, plant and equipment, net
Goodwill
Other intangible assets with indefinite lives
Finite-lived intangible assets, net
Restricted cash
Other non-current assets
Investments in unconsolidated entities
Deferred tax assets
Non-current income tax receivable
Assets held for sale - non-current
Total assets
Current liabilities:
Short-term debt and current portion of long-term debt
Current portion of capital lease obligations
Accounts payable
Accrued expenses and other current liabilities
Liabilities related to assets held for sale - current
Total current liabilities
Long-term liabilities:
Long-term debt, net of current portion
Capital lease obligations, net of current portion
Deferred tax liabilities
Other long-term liabilities
Liabilities related to assets held for sale - non-current
Total long-term liabilities
Stockholders' equity:
Series B preferred stock, $0.001 par value (liquidation preference: $709,701 at June 30, 2017 and December 31, 2016); Authorized: 2,300 shares; Issued: 2,065 shares at June 30, 2017 and December 31, 2016; Outstanding: 1,774 shares at June 30, 2017 and December 31, 2016
Total series B preferred stock, $0.001 par value (liquidation preference: $709,701 at June 30, 2017 and December 31, 2016); Authorized: 2,300 shares; Issued: 2,065 shares at June 30, 2017 and December 31, 2016; Outstanding: 1,774 shares at June 30, 2017 and December 31, 2016
Common stock, $0.001 par value; Authorized: 200,000 shares; Issued: 95,121 shares and 94,770 shares at June 30, 2017 and December 31, 2016, respectively; Outstanding: 87,442 shares and 87,091 shares at June 30, 2017 and December 31, 2016, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost, 7,679 shares at June 30, 2017 and December 31, 2016
Accumulated other comprehensive loss
Total stockholders' equity
Non-controlling interests
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support